DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low – Should You Sell?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) reached a new 52-week low during mid-day trading on Friday . The company traded as low as $9.36 and last traded at $9.38, with a volume of 9306449 shares traded. The stock had previously closed at $10.14.

Analysts Set New Price Targets

Several research firms recently issued reports on XRAY. BMO Capital Markets reduced their price target on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research report on Thursday. Piper Sandler upped their price objective on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a research note on Monday, August 10th. Finally, Barclays boosted their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Three research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $13.31.

DENTSPLY SIRONA Trading Up 1.7%

The company has a market capitalization of $1.90 billion, a P/E ratio of -3.47, a PEG ratio of 1.21 and a beta of 0.84. The company’s fifty day simple moving average is $11.91 and its 200-day simple moving average is $11.49. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The business had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. During the same period in the previous year, the company posted $0.52 earnings per share. The firm’s revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.4 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Tidal Investments LLC increased its stake in shares of DENTSPLY SIRONA by 13.1% in the 2nd quarter. Tidal Investments LLC now owns 371,967 shares of the medical instruments supplier’s stock valued at $3,947,000 after purchasing an additional 43,025 shares in the last quarter. Engineers Gate Manager LP increased its position in shares of DENTSPLY SIRONA by 451.5% during the 2nd quarter. Engineers Gate Manager LP now owns 124,810 shares of the medical instruments supplier’s stock worth $1,324,000 after purchasing an additional 102,179 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $791,000. Allworth Financial LP boosted its stake in shares of DENTSPLY SIRONA by 163.8% in the second quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 2,990 shares during the period. Finally, Nykredit A S purchased a new stake in DENTSPLY SIRONA during the 2nd quarter worth about $38,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.